Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Novel PDE5 inhibitors developed by Lilly Icos researchers

Oct. 18, 2002

cGMP-selective PDE inhibitors under study at Bayer

Oct. 18, 2002

Duloxetine in urinary stress incontinence

Oct. 17, 2002

Novel potassium channel openers under study at Abbott

Oct. 17, 2002

Novel agents for urinary incontinence covered by Boehringer Ingelheim patent

Oct. 15, 2002

Merck patent covers novel alpha1A-adrenoceptor antagonists and their use in BPH

Oct. 14, 2002

Dutasteride approved for launch as first dual-acting 5alpha-reductase inhibitor for BPH

Oct. 11, 2002

Novel small-molecule leads targeting the V2 vasopressin receptor

Oct. 11, 2002

Reduction of RCN incidence with fenoldopam mesilate after contrast angiography

Oct. 10, 2002

Keryx extends manufacturing and negotiating rights for KRX-101

Oct. 8, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....